» Articles » PMID: 26177847

Safe Days in Space with Acceptable Uncertainty from Space Radiation Exposure

Overview
Date 2015 Jul 17
PMID 26177847
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The prediction of the risks of cancer and other late effects from space radiation exposure carries large uncertainties mostly due to the lack of information on the risks from high charge and energy (HZE) particles and other high linear energy transfer (LET) radiation. In our recent work new methods were used to consider NASA's requirement to protect against the acceptable risk of no more than 3% probability of cancer fatality estimated at the 95% confidence level. Because it is not possible that a zero-level of uncertainty could be achieved, we suggest that an acceptable uncertainty level should be defined in relationship to a probability distribution function (PDF) that only suffers from modest skewness with higher uncertainty allowed for a normal PDF. In this paper, we evaluate PDFs and the number or "safe days" in space, which are defined as the mission length where risk limits are not exceeded, for several mission scenarios at different acceptable levels of uncertainty. In addition, we briefly discuss several important issues in risk assessment including non-cancer effects, the distinct tumor spectra and lethality found in animal experiments for HZE particles compared to background or low LET radiation associated tumors, and the possibility of non-targeted effects (NTE) modifying low dose responses and increasing relative biological effectiveness (RBE) factors for tumor induction. Each of these issues skew uncertainty distributions to higher fatality probabilities with the potential to increase central values of risk estimates in the future. Therefore they will require significant research efforts to support space exploration within acceptable levels of risk and uncertainty.

Citing Articles

Evaluation of deep space exploration risks and mitigations against radiation and microgravity.

Dobney W, Mols L, Mistry D, Tabury K, Baselet B, Baatout S Front Nucl Med. 2024; 3:1225034.

PMID: 39355042 PMC: 11440958. DOI: 10.3389/fnume.2023.1225034.


Comparison of dose and risk estimates between ISS Partner Agencies for a 30-day lunar mission.

Shavers M, Semones E, Shurshakov V, Dobynde M, Sato T, Komiyama T Z Med Phys. 2023; 34(1):31-43.

PMID: 38030484 PMC: 10919970. DOI: 10.1016/j.zemedi.2023.10.005.


High-LET-Radiation-Induced Persistent DNA Damage Response Signaling and Gastrointestinal Cancer Development.

Kumar K, Kumar S, Datta K, Fornace Jr A, Suman S Curr Oncol. 2023; 30(6):5497-5514.

PMID: 37366899 PMC: 10297158. DOI: 10.3390/curroncol30060416.


Comparison of biological measurement and physical estimates of space radiation in the International Space Station.

Yoshida K, Hada M, Kizu A, Kitada K, Eguchi-Kasai K, Kokubo T Heliyon. 2022; 8(8):e10266.

PMID: 36061033 PMC: 9433677. DOI: 10.1016/j.heliyon.2022.e10266.


Considerations for practical dose equivalent assessment of space radiation and exposure risk reduction in deep space.

Naito M, Kodaira S Sci Rep. 2022; 12(1):13617.

PMID: 35948565 PMC: 9365775. DOI: 10.1038/s41598-022-17079-1.